Menopause can affect the vulva, vagina, bladder and urethra as estrogen levels decline. Vaginal dryness is common, but it can appear alongside burning, irritation, pain with penetration, urinary urgency or recurrent urinary infections. These changes are often grouped under genitourinary syndrome of menopause, or GSM. Unlike hot flashes, GSM often persists or progresses without treatment.
The clinic’s Vaginal Dryness guide explains the concern, while Menopause Symptoms places dryness within the wider menopause transition. Treatment should match the cause, symptom severity and medical history.
Start With Non-Hormonal Options
For mild dryness or friction during sex, vaginal lubricants and moisturizers are often reasonable first steps.
Lubricants are used around sexual activity to reduce friction. Moisturizers are used regularly to improve ongoing moisture and comfort. Canadian guidance lists both as first-line options for genitourinary symptoms of menopause.
If symptoms persist, especially with burning, urinary symptoms or pain during penetration, medical assessment becomes more useful.
Local Vaginal Estrogen Is an Established Option
When vaginal dryness is related to menopause and non-hormonal measures are not enough, local vaginal estrogen is a well-established treatment.
Canadian guidance lists vaginal estrogen as a second-line treatment for GSM after moisturizers and lubricants. It is available as creams, tablets and rings. Because these products act mainly in vaginal tissue, systemic absorption is low compared with systemic hormone therapy. Canadian guidance also notes that low-dose vaginal estrogen does not generally require added progesterone for endometrial protection, even in someone who has a uterus.
Medical history still matters, especially with unexplained vaginal bleeding, a history of estrogen-sensitive cancer or other circumstances requiring individualized review.
The clinic’s Hormone Assessment & Therapy service can place local symptoms within the wider menopause picture when hot flashes, sleep disruption or other hormonal concerns are also present.
Systemic Hormone Therapy Has a Different Role
Systemic estrogen, delivered through forms such as patches, gels or tablets, is used when menopause symptoms affect the whole body, particularly troublesome hot flashes and night sweats. It can also improve GSM symptoms, but someone whose main issue is vaginal dryness may not need systemic therapy solely for that reason.
The decision depends on age, time since menopause, medical history, symptoms and contraindications. When systemic estrogen is used in someone with a uterus, endometrial protection with a progestogen is usually needed.
Pelvic Floor Physiotherapy May Help
Dryness is not always the only reason intercourse becomes uncomfortable. Pain can also involve pelvic-floor muscle tension, scar tissue, previous childbirth injury or other musculoskeletal factors. Canadian menopause guidance includes pelvic-floor physiotherapy among management options for genitourinary symptoms.
The clinic’s Women’s Intimate-Health Treatment pathway begins with assessment because dryness, pain, laxity and urinary concerns can overlap without sharing the same cause.
Energy-Based Vaginal Treatments Need Caution
Laser and radiofrequency procedures are sometimes marketed as “vaginal rejuvenation” for dryness, laxity, sexual function or urinary symptoms. The evidence is less established than the marketing can suggest.
The Society of Obstetricians and Gynaecologists of Canada has stated that long-term use of intravaginal laser therapy for GSM or stress urinary incontinence remains experimental and should be studied through well-designed clinical trials. Health Canada also requires evidence of acceptable risk and benefit for therapeutic energy-based medical devices and highlights the potential for thermal injury.
Anti-Aging Vancouver’s Women’s Intimate-Health Treatment page reflects this caution. Established medical options are considered first, and energy-based or regenerative procedures should not replace them.
PRP Is an Emerging Option
Platelet-rich plasma, or PRP, is sometimes offered for intimate-health symptoms. It is prepared from a person’s own blood and injected into selected tissue.
For vaginal dryness and GSM, PRP remains investigational rather than an established first-line treatment. Evidence is not strong enough to place it ahead of lubricants, moisturizers, local estrogen or other established therapies. The clinic likewise describes PRP for intimate-health symptoms as investigational rather than established.
If PRP is discussed, useful questions include what symptom it is intended to address, what evidence supports that use and what risks apply.
When Dryness May Not Be Menopause
Menopause is a common cause of vaginal dryness, but it is not the only one.
Dryness can also occur during breastfeeding, after treatments that lower estrogen, with certain medications, vulvar skin conditions, irritation from soaps or douches, autoimmune conditions, infection or reduced arousal. The clinic’s vaginal-dryness guidance emphasizes identifying the cause rather than assuming menopause automatically.
That is why unusual discharge, sores, severe pain, new bleeding or persistent irritation should not simply be labelled “menopause.” Any new vaginal bleeding after menopause should be medically assessed.
What an Assessment May Review
A clinician may ask about:
when dryness began and whether it is worsening
menopausal status and other menopause symptoms
pain during sex or pelvic examinations
urinary urgency, burning or recurrent infections
medications and cancer-treatment history
vaginal products or irritants
bleeding, discharge or skin changes
previous hormone therapy
A gentle examination may be offered when appropriate and with consent. Tests are sometimes used when infection, skin disease or another condition is suspected.
Frequently Asked Questions
Are vaginal moisturizers and lubricants the same?
No. Lubricants are generally used around sexual activity to reduce friction. Moisturizers are used regularly to support ongoing comfort and moisture.
Is vaginal estrogen the same as systemic hormone therapy?
No. Low-dose vaginal estrogen acts mainly in local tissue, while systemic hormone therapy circulates throughout the body and is used for broader menopause symptoms.
Do vaginal dryness symptoms eventually disappear?
Not necessarily. GSM often persists or becomes more noticeable after menopause if untreated, unlike hot flashes, which may lessen with time.
Is laser treatment the next step if estrogen is not suitable?
Not automatically. Other established and non-hormonal options may be available, and energy-based vaginal treatments have important evidence limitations.
Treat the Cause, Not Just the Dryness
Menopause-related vaginal dryness is common and treatable, but the right option depends on what is causing the symptoms and what else is happening. Lubricants and moisturizers may be enough for mild symptoms. Local vaginal estrogen is an established treatment when GSM persists. Pelvic-floor care or broader hormone assessment may matter in selected cases.
Energy-based procedures and PRP deserve a more cautious conversation because their evidence is less established.
If dryness, pain or urinary symptoms are affecting comfort or intimacy, the clinic’s Contact page can be used to arrange a confidential assessment and discuss which options fit the symptoms and medical history.